Literature DB >> 8419817

Serum cholesterol in young men and subsequent cardiovascular disease.

M J Klag1, D E Ford, L A Mead, J He, P K Whelton, K Y Liang, D M Levine.   

Abstract

BACKGROUND: The increased risk of cardiovascular disease associated with higher serum cholesterol levels in middle-aged persons has been clearly established, but there have been few opportunities to examine a potential link between serum cholesterol levels measured in young men and clinically evident premature cardiovascular disease later in life.
METHODS: We performed a prospective study of 1017 young men (mean age, 22 years) followed for 27 to 42 years to quantify the risk of cardiovascular disease and total mortality associated with serum cholesterol levels during early adult life. The mean serum cholesterol level at entry was 192 mg per deciliter (5.0 mmol per liter).
RESULTS: During a median follow-up of 30.5 years, there were 125 cardiovascular-disease events, 97 of which were due to coronary heart disease. The serum cholesterol level at base line was strongly associated with the incidence of events related to coronary heart disease and cardiovascular disease, as well as to total mortality and mortality due to cardiovascular disease. The risks were similar whether the events occurred before or after the age of 50. In a proportional-hazards analysis adjusted for age, body-mass index (the weight in kilograms divided by the square of the height in meters), the level of physical activity, coffee intake, change in smoking status, and the incidence of diabetes and hypertension during follow-up, a difference in the serum cholesterol level at base line of 36 mg per deciliter (0.9 mmol per liter)--the difference between the 25th and 75th percentiles of cholesterol level in the study population at base line--was associated with an increased risk of cardiovascular disease (relative risk, 1.72; 95 percent confidence interval, 1.39 to 2.14), coronary heart disease (relative risk, 2.01; 95 percent confidence interval, 1.59 to 2.53), and mortality due to cardiovascular disease (relative risk, 2.02; 95 percent confidence interval, 1.23 to 3.32). A difference in the base-line serum cholesterol level of 36 mg per deciliter was significantly associated with an increased risk of death before the age of 50 (relative risk, 1.64; 95 percent confidence interval, 1.03 to 2.61), but not with the overall risk of death (relative risk, 1.21; 95 percent confidence interval, 0.93 to 1.58).
CONCLUSIONS: These findings indicate a strong association between the serum cholesterol level measured early in adult life in men and cardiovascular disease in midlife.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419817     DOI: 10.1056/NEJM199302043280504

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  70 in total

Review 1.  Isoprenoids as mediators of the biological effects of statins.

Authors:  James K Liao
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

2.  Primary prevention: the unsettling question.

Authors:  John C LaRosa
Journal:  Curr Atheroscler Rep       Date:  2005-02       Impact factor: 5.113

3.  Origins of disparities in cardiovascular disease: birth weight, body mass index, and young adult systolic blood pressure in the national longitudinal study of adolescent health.

Authors:  Liana J Richardson; Jon M Hussey; Kelly L Strutz
Journal:  Ann Epidemiol       Date:  2011-04-16       Impact factor: 3.797

4.  Reliability of alcohol recall after 15 years and 23 years of follow-up in the Johns Hopkins Precursors Study.

Authors:  Audrey Y Chu; Lucy A Meoni; Nae Yuh Wang; Kung-Yee Liang; Daniel E Ford; Michael J Klag
Journal:  J Stud Alcohol Drugs       Date:  2010-01       Impact factor: 2.582

5.  Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging.

Authors:  Eric M Reiman; Kewei Chen; Jessica B S Langbaum; Wendy Lee; Cole Reschke; Daniel Bandy; Gene E Alexander; Richard J Caselli
Journal:  Neuroimage       Date:  2009-07-23       Impact factor: 6.556

6.  Non-invasive assessment of endothelial function.

Authors:  M J Mullen; S A Thorne; J E Deanfield; C J Jones
Journal:  Heart       Date:  1997-04       Impact factor: 5.994

7.  Stability of preferences for end-of-life treatment after 3 years of follow-up: the Johns Hopkins Precursors Study.

Authors:  Marsha N Wittink; Knashawn H Morales; Lucy A Meoni; Daniel E Ford; Nae-Yuh Wang; Michael J Klag; Joseph J Gallo
Journal:  Arch Intern Med       Date:  2008-10-27

Review 8.  Understanding risk in hypercholesterolemia.

Authors:  John C LaRosa
Journal:  Clin Cardiol       Date:  2003-01       Impact factor: 2.882

Review 9.  The role of early LDL lowering to prevent the onset of atherosclerotic disease.

Authors:  Brian A Ference; Nitin Mahajan
Journal:  Curr Atheroscler Rep       Date:  2013-04       Impact factor: 5.113

10.  Histone deacetylase inhibitors: a new mode for inhibition of cholesterol metabolism.

Authors:  Sridar V Chittur; Niquiche Sangster-Guity; Paulette J McCormick
Journal:  BMC Genomics       Date:  2008-10-29       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.